Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Bone tissue engineering aims to harness materials to develop functional bone tissue to heal 'critical-sized' bone defects. This study examined a robust, coated poly(caprolactone) trimethacrylate (PCL-TMA) 3D-printable scaffold designed to augment bone formation. Following optimisation of the coatings, three bioactive coatings were examined, i) elastin-like polypeptide (ELP), ii) poly(ethyl acrylate) (PEA), fibronectin (FN) and bone morphogenetic protein-2 (BMP-2) applied sequentially (PEA/FN/BMP-2) and iii) both ELP and PEA/FN/BMP-2 coatings applied concurrently. The scaffold material was robust and showed biodegradability. The coatings demonstrated a significant (p 

Original publication

DOI

10.1038/s41598-024-75198-3

Type

Journal article

Journal

Sci Rep

Publication Date

28/10/2024

Volume

14

Keywords

Animal models, Bioactive coating, Biomaterial, Bone tissue engineering, CAM assay, Tissue Scaffolds, Tissue Engineering, Animals, Bone Morphogenetic Protein 2, Osteogenesis, Mice, Bone and Bones, Polyesters, Alkaline Phosphatase, Humans, Biocompatible Materials, Coated Materials, Biocompatible